Top

Published in:

01-12-2002

Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States)

Authors: Ikuko Kato, Karen L. Koenig, Roy E. Shore, Mark S. Baptiste, Patricia P. Lillquist, Glauco Frizzera, Jerome S. Burke, Hiroko Watanabe

Published in: Cancer Causes & Control | Issue 10/2002

Title: Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States)
Authors: Ikuko Kato
Karen L. Koenig
Roy E. Shore
Mark S. Baptiste
Patricia P. Lillquist
Glauco Frizzera
Jerome S. Burke
Hiroko Watanabe
Publication date: 01-12-2002
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 10/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1023/A:1021953224822

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 10/2002

Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan

Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study

Toenail selenium concentration and lung cancer in male smokers (Finland)

Postmenopausal breast cancer is associated with high intakes of ω6 fatty acids (Sweden)

Re: Diagnostic radiation and the risk of multiple myeloma (United States)

Response – Diagnostic radiation and the risk of multiple myeloma (United States)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer